KAT6A and acute myeloid leukemia: The screen was also biologically successful, with the DMSO-treated branch capturing as top hits several known drivers of AML differentiation arrest, such as Mediator complex subunits, Dot1l, Kat6a, and Rcor1, the structural subunit of the LSD1-containing co-REST complex.